Jazz Pharmaceuticals plc (JAZZ)
NASDAQ: JAZZ · Real-Time Price · USD
122.92
-3.48 (-2.75%)
At close: Mar 28, 2025, 4:00 PM
125.00
+2.08 (1.69%)
After-hours: Mar 28, 2025, 5:42 PM EDT
Jazz Pharmaceuticals Employees
Jazz Pharmaceuticals had 2,800 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
2,800
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$1,453,196
Profits / Employee
$200,043
Market Cap
11.44B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
JAZZ News
- 3 days ago - Jazz Pharmaceuticals to Participate in the 24th Annual Needham Virtual Healthcare Conference - PRNewsWire
- 10 days ago - Jazz Pharmaceuticals to Showcase Research Demonstrating Treatment Benefits of Xywav® (calcium, magnesium, potassium, and sodium oxybates) Oral Solution and Epidiolex® (cannabidiol) at American Academy of Neurology Annual Meeting - PRNewsWire
- 19 days ago - CHIMERIX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Chimerix, Inc. - CMRX - Business Wire
- 24 days ago - Jazz Pharma To Buy Chimerix For $935 Million, Strengthening Rare Cancer Pipeline - Benzinga
- 24 days ago - Jazz Pharmaceuticals to buy Chimerix for $935 million - Reuters
- 24 days ago - Jazz Pharmaceuticals to Acquire Chimerix, Further Diversifying Oncology Portfolio - GlobeNewsWire
- 4 weeks ago - Jazz Pharmaceuticals: Decent 2025 Outlook, Extended Timeline For Zanidatamab - Seeking Alpha
- 4 weeks ago - Jazz Pharmaceuticals plc (JAZZ) Q4 2024 Earnings Call Transcript - Seeking Alpha